{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:19:02Z","timestamp":1782886742644,"version":"3.54.5"},"reference-count":82,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T00:00:00Z","timestamp":1325808000000},"content-version":"vor","delay-in-days":1619,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:p>Evidence\u2010based clinical practice guidelines encapsulate current knowledge to guide health care professionals in the treatment of patients with unstable angina or non\u2013ST\u2010segment\u2010elevation myocardial infarction (NSTEMI), yet adherence to guideline recommendations is suboptimal. Guideline adherence may be improved by quality improvement programs such as the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation?) National Quality Improvement Initiative of the American College of Cardiology\u2013American Heart Association Guidelines. The CRUSADE data have been analyzed to demonstrate that overall guideline adherence is directly associated with mortality and that improvement in guideline adherence saves lives. Also, the CRUSADE data have determined that the real\u2010life mortality risk associated with unstable angina and NSTEMI is greater than suggested by clinical trials. The newer antiplatelet drugs recommended in early intervention and discharge treatment strategies are underused across many segments of the unstable angina\u2013NSTEMI population. Glycoprotein IIb\u2010IIIa inhibitors are underused in high\u2010risk populations, and clopidogrel is markedly underused in patients who are medically managed rather than undergoing percutaneous coronary intervention or coronary artery bypass graft surgery. In addition, often the specialty of the treating physician and the status of the hospital influence the use of antiplatelet therapy. The reasons for underprescribing of antiplatelet drugs by physicians are not entirely clear but may be related to a lack of guideline familiarity and understanding, as well as factors such as drug novelty, safety, and cost. Continued education and data dissemination are therefore vital in promoting the prescription of guideline\u2010recommended drugs, both in the early hospitalization phase and as patients transition to community\u2010based care. The role of the pharmacist is pivotal in ensuring adherence to clinical guidelines by interacting with both the physician and patient.<\/jats:p>","DOI":"10.1592\/phco.27.8.1145","type":"journal-article","created":{"date-parts":[[2007,7,27]],"date-time":"2007-07-27T09:57:57Z","timestamp":1185530277000},"page":"1145-1162","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Antiplatelet Therapy in Patients with Unstable Angina and Non\u2013ST\u2010Segment\u2010Elevation Myocardial Infarction: Findings from the CRUSADE National Quality Improvement Initiative"],"prefix":"10.1002","volume":"27","author":[{"given":"Michael B.","family":"Bottorff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith A.","family":"Nutescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Spinler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,6]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00996-7"},{"key":"e_1_2_1_3_2","unstructured":"HallMP PopovicJR.1998 national hospital discharge survey 316. Vital and health statistics of the Centers for Disease Control and Prevention June 30 2000. Available fromhttp:www.cdc.govnchsdataadad316.pdf. Accessed August 3 2006."},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.2165\/00129784-200505060-00007"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000037106.76139.53"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.513S"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00466-5"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(03)00388-0"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.15.1458"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02537-8"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-817692"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.20.2578"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.22.2871"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.17.1358"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzh051"},{"key":"e_1_2_1_16_2","first-page":"480","article-title":"Improving care for acute myocardial infarction: experience from the cooperative cardiovascular project","volume":"24","author":"The Cooperative Cardiovascular Project Best Practices Working Group","year":"1998","journal-title":"Jt Comm J Qual Improv"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.16.1939"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E640"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/ajhp\/61.24.2672","article-title":"Pharmacist interventions to improve the management of coronary artery disease","volume":"61","author":"Chapman NR","year":"2004","journal-title":"Am J Health-Syst Pharm"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000134791.68010.FA"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)01519-8"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.2.203"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06700-9"},{"key":"e_1_2_1_24_2","unstructured":"American Heart Association.Get with the guidelines program 2006. Available fromhttp:www.americanheart.orgpresenter.jhtmlidentifier1165. Accessed June 15 2006."},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.07.083"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.10.1269"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.12.083"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.172860"},{"key":"e_1_2_1_29_2","unstructured":"Joint Commission on Accreditation of Healthcare Organizations.Acute myocardial infarction national quality measures. Available fromhttp:www.jointcommission.orgNRrdonlyres42AE880A\u201079424A7B\u2010B63E\u20106D8637264A5402a_AMI_List.pdf. Accessed June 23 2006."},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1197\/aemj.9.11.1146"},{"key":"e_1_2_1_31_2","unstructured":"Duke Clinical Research Institute.The CRUSADE national quality improvement initiative 2006 2nd quarter results. Available fromhttp:www.crusadeqi.comMainHomePage.shtml. Accessed June 15 2006."},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.174516"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6921.81"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808133390704"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2003.09.001"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.20.2045"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106213442501"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.25.2829"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1988.03410150107041"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010746"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000112577.69066.CB"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.17.2096"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.11.055"},{"key":"e_1_2_1_44_2","first-page":"29","article-title":"The effect of insurance type on use of evidence\u2010based therapies in high\u2010risk acute coronary syndromes: results from CRUSADE [abstract]","volume":"109","author":"Calvin JE","year":"2004","journal-title":"Circulation"},{"key":"e_1_2_1_45_2","first-page":"28","article-title":"Hispanic patients with non\u2014ST\u2010segment elevation acute coronary syndromes receive less evidence\u2010based care and are less frequently managed by a cardiologist: results from CRUSADE [abstract]","volume":"109","author":"Cohen MG","year":"2004","journal-title":"Circulation"},{"key":"e_1_2_1_46_2","first-page":"518","article-title":"Sub\u2010optimal care for non\u2014ST\u2010segment elevation acute coronary syndrome patients presenting with congestive heart failure is associated with higher mortality [abstract]","volume":"110","author":"Goswami R","year":"2004","journal-title":"Circulation"},{"key":"e_1_2_1_47_2","first-page":"784","article-title":"Relationship of renal insufficiency to the quality of non\u2014ST\u2010segment elevation acute coronary syndromes care and outcomes: results from the CRUSADE initiative [abstract]","volume":"110","author":"Han JH","year":"2004","journal-title":"Circulation"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1197\/j.aem.2004.11.029"},{"key":"e_1_2_1_49_2","first-page":"410","article-title":"Underutilization of revascularization in early cardiogenic shock among patients with non\u2014ST\u2010segment elevation acute coronary syndromes: observations from the CRUSADE initiative [abstract]","volume":"110","author":"Ohman EM","year":"2004","journal-title":"Circulation"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000157732.03358.64"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.7.806"},{"key":"e_1_2_1_52_2","first-page":"420","article-title":"Patients with non\u2014ST\u2010segment elevation acute coronary syndromes receive less aggressive discharge care after bypass surgery versus percutaneous coronary intervention [abstract]","volume":"110","author":"Dyke CK","year":"2004","journal-title":"Circulation"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000140675.85342.1B"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07442-1"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00514-X"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.11.012"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(03)00517-9"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.03.029"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.13.joc60034"},{"key":"e_1_2_1_60_2","first-page":"5A","article-title":"Early treatment for non\u2014ST\u2010segment elevation acute coronary syndromes is associated with appropriate discharge care: the CRUSADE experience [abstract]","volume":"45","author":"Gibler WB","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)82863-2"},{"key":"e_1_2_1_62_2","first-page":"e310","article-title":"Do rural hospitals provide timely and effective care for patients with non\u2014ST\u2010segment elevation acute coronary syndromes?","volume":"111","author":"Cairns CB","year":"2005","journal-title":"Circulation"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.10.008"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.24.3108"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382102"},{"key":"e_1_2_1_66_2","first-page":"45","article-title":"Enoxaparin vs unfractionated heparin in high\u2010risk patients with non\u2014ST\u2010segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial","volume":"292","author":"Ferguson JJ","year":"2004","journal-title":"JAMA"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00889-5"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.11.014"},{"key":"e_1_2_1_69_2","first-page":"32","article-title":"Regional variation in the treatment and outcomes of patients with unstable angina\/STEMI [abstract]","volume":"109","author":"Menon V","year":"2004","journal-title":"Circulation"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.16.1912"},{"key":"e_1_2_1_71_2","first-page":"785","article-title":"Associating changes in hospital non\u2014ST\u2010segment elevation acute coronary syndromes guidelines adherence with changes in patient outcomes: results from CRUSADE [abstract]","volume":"110","author":"Peterson ED","year":"2004","journal-title":"Circulation"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020353"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02670-0"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05701-4"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000134791.68010.FA"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200321160-00001"},{"key":"e_1_2_1_77_2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/01.CIR.101.4.366","article-title":"Cost\u2010effectiveness of platelet glycoprotein IIb\/IIIa inhibition with eptifibatide in patients with non\u2014ST\u2010elevation acute coronary syndromes","volume":"101","author":"Mark DB","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200119010-00003"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2005.06.026"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.11.051"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-4-200502150-00007"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.10.041"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200206063462309"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.27.8.1145","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.27.8.1145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:15:35Z","timestamp":1761052535000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.27.8.1145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":82,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1592\/phco.27.8.1145"],"URL":"https:\/\/doi.org\/10.1592\/phco.27.8.1145","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"2012-01-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}